Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity

• Päätekijät: Yeyu Qin (Tekijä), Jing Xie (Tekijä), Ruihe Zheng (Tekijä), Yuhang Li (Tekijä), Haixia Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Doxorubicin (DOX) is one of the most common chemotherapeutic anti-cancer drugs. However, its clinical use is restricted by serious cardiotoxicity. Oleoylethanolamide (OEA), a structural congener of endocannabinoid anandamide, is the endogenous agonist of peroxisome proliferator activated-receptor α...